alendronate and curcumin

alendronate has been researched along with curcumin in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	7 (87.50)	24.3611
2020's	1 (12.50)	2.80

Authors

Authors	Studies
Gryczynski, Z; Ranjan, AP; Raut, SL; Thamake, SI; Vishwanatha, JK	1
Cho, DC; Jeon, Y; Kim, KT; Sung, JK	1
Chen, D; Dong, X; Fan, H; Guo, C; Wang, K; Yin, J; Zhao, F; Zou, S	1
Abourehab, MAS; Dong, J; Hussain, Z; Tao, L	1
Chen, D; Dong, X; Guo, C; Liu, W; Wang, B; Wang, K; Yu, Y	1
Ahmadi, MRH; Asadollahi, K; Khanizadeh, F; Rahmani, A	1
Chen, D; He, H; Jiang, T; Shen, Y; Wang, W; Webster, TJ; Wen, J; Xi, Y; Xu, N; Xue, M; Ye, X; Yu, J; Yu, Y	1
Kamble, S; Müllner, M; Pelras, T; Rohanizadeh, R; Varamini, P	1

Trials

1 trial(s) available for alendronate and curcumin

Article	Year
Combination therapy of curcumin and alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis. Archives of endocrinology and metabolism, 2018, Volume: 62, Issue:4 Topics: Aged; Alendronate; Alkaline Phosphatase; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Collagen Type II; Curcumin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Peptide Fragments	2018

Article

Year

Combination therapy of curcumin and alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis.

Archives of endocrinology and metabolism, 2018, Volume: 62, Issue:4

Topics: Aged; Alendronate; Alkaline Phosphatase; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Collagen Type II; Curcumin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Peptide Fragments

2018

Other Studies

7 other study(ies) available for alendronate and curcumin

Article	Year
Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer. Biomaterials, 2012, Volume: 33, Issue:29 Topics: Alendronate; Animals; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Boronic Acids; Bortezomib; Breast Neoplasms; Curcumin; Drug Carriers; Female; Humans; Lactic Acid; Mice; Mice, Nude; Nanoparticles; Neoplasm Metastasis; Osteoporosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrazines	2012
A synergistic bone sparing effect of curcumin and alendronate in ovariectomized rat. Acta neurochirurgica, 2012, Volume: 154, Issue:12 Topics: Alendronate; Alkaline Phosphatase; Animals; Bone and Bones; Bone Density; Bone Remodeling; Collagen Type I; Curcumin; Drug Synergism; Drug Therapy, Combination; Female; Lumbar Vertebrae; Osteocalcin; Osteoporosis; Ovariectomy; Rats; Rats, Sprague-Dawley	2012
Multifunctional redox-responsive and CD44 receptor targeting polymer-drug nanomedicine based curcumin and alendronate: synthesis, characterization and in vitro evaluation. Artificial cells, nanomedicine, and biotechnology, 2018, Volume: 46, Issue:sup1 Topics: Alendronate; Antineoplastic Agents; Biological Transport; Chemistry Techniques, Synthetic; Curcumin; Drug Carriers; Drug Liberation; Humans; Hyaluronan Receptors; MCF-7 Cells; Micelles; Molecular Targeted Therapy; Nanomedicine; Oxidation-Reduction; Polymers	2018
Design and development of novel hyaluronate-modified nanoparticles for combo-delivery of curcumin and alendronate: fabrication, characterization, and cellular and molecular evidences of enhanced bone regeneration. International journal of biological macromolecules, 2018, Volume: 116 Topics: Alendronate; Animals; Antigens, Differentiation; Bone Regeneration; Cell Differentiation; Cell Line; Curcumin; Drug Delivery Systems; Hyaluronic Acid; Mice; Nanoparticles; Osteoblasts	2018
In Vivo Evaluation of Reduction-Responsive Alendronate-Hyaluronan-Curcumin Polymer-Drug Conjugates for Targeted Therapy of Bone Metastatic Breast Cancer. Molecular pharmaceutics, 2018, 07-02, Volume: 15, Issue:7 Topics: Alendronate; Animals; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Curcumin; Drug Carriers; Drug Liberation; Female; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hydrogen-Ion Concentration; Mice; Mice, Nude; Micelles; Oxidation-Reduction; Particle Size; Polymers; Treatment Outcome; Xenograft Model Antitumor Assays	2018
Dual targeting curcumin loaded alendronate-hyaluronan- octadecanoic acid micelles for improving osteosarcoma therapy. International journal of nanomedicine, 2019, Volume: 14 Topics: Alendronate; Animals; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Curcumin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Hyaluronic Acid; Male; Mice, Nude; Micelles; Osteosarcoma; Particle Size; Polymers; Proton Magnetic Resonance Spectroscopy; Stearic Acids	2019
Bisphosphonate-functionalized micelles for targeted delivery of curcumin to metastatic bone cancer. Pharmaceutical development and technology, 2020, Volume: 25, Issue:9 Topics: Alendronate; Antineoplastic Agents; Bone Neoplasms; Curcumin; Diphosphonates; Drug Carriers; Drug Delivery Systems; Drug Liberation; Durapatite; Micelles; Nanoparticles; Particle Size; Poloxamer; Polymers; Tumor Microenvironment	2020